0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Thermo Fisher Scientific Inc - Trending symbols

Latest News of Thermo Fisher Scientific Inc

DateTitleRead
2025-07-11
10:02
Ultrasensitive Molecular Amplification Market Research 2025-2035 | Demand Surges for Early Detection, Molecular Amplification Techniques Lead the WayRead
2025-07-10
13:31
Tecan stock rises after CEO change announcementRead
2025-07-09
14:21
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?Read
2025-07-08
15:34
TMO Quantitative Stock AnalysisRead
2025-07-08
14:10
Evercore adds seven life science stocks to TAP Outperform listRead
2025-07-06
09:35
FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express TestRead
2025-07-06
09:35
Wells Fargo maintained a Buy rating on Thermo Fisher Scientific (TMO)Read
2025-07-04
19:17
Thermo Fisher Scientific (NYSE:TMO) Gains FDA Approval for Rapid Cancer Diagnostic ToolRead
2025-07-04
15:34
Validea Detailed Fundamental Analysis - TMORead
2025-06-30
18:43
From Agilent to ZEISS: SDi's 2025 Report Dissects Market Share and Growth Across 21 Lab Instrument LeadersRead



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Other Stockholders Equity -705,000167,000-538,000142,000-396,000-902,000-1,298,00052,998,00051,700,000
Income Tax Expense 281,000-153,000128,000-29,00099,00051,000150,000-245,000-95,000
Current Deferred Revenue 2,547,000142,0002,689,000-57,0002,632,000-41,0002,591,000-5,197,000-2,606,000
Total Other Income Expense Net -183,000113,000-70,000-44,000-114,000-17,000-131,000138,0007,000
Long-term Assets Other -2,849,000-127,000-2,976,000134,000-2,842,000222,000-2,620,0006,619,0003,999,000
Interest Expense 269,00031,000300,00026,000326,00033,000359,000-749,000-390,000
Minority Interest -1,000-4,000-5,0001,000-4,0001,000-3,0005,0002,000

Comments

How you think about this?

Leave a comment

Stay informed about Thermo Fisher Scientific Inc.

Receive notifications about Thermo Fisher Scientific Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.